A dual function for adenosine 5'-triphosphate in the regulation of vascular tone is considered. Adenosine 5'-triphosphate can cause vasodilation, acting via P 2 -purinoceptors located on vascular endothelial cells to release an endothelium-derived relaxing factor which diffuses to the vascular smooth muscle and induces vasodilation. The main source of intraluminal adenosine 5'-triphosphate is likely to be endothelial cells, and its release can be measured during pathophysiological conditions such as ischemia and hypoxia, in amounts likely to be sufficient to activate endothelial P 2 -purinoceptors. Adenosine 5'-triphosphate can also be released during intravascular platelet aggregation and from intact and damaged vascular smooth muscle cells, and so may play a role in the complex physiological mechanisms controlling local vascular tone under normoxic conditions and during vessel injury. Evidence is also presented for adenosine 5'triphosphate acting as an excitatory cotransmitter with noradrenaline from sympathetic perivascular nerves, to cause vasoconstriction via excitatory P 2 -purinoceptors located on vascular smooth muscle. The postjunctional mechanical and electrical responses of a number of blood vessels following perivascular nerve stimulation contain a component that is resistant to blockade of the a-adrenoceptor. This nonadrenergic response is mimicked by adenosine 5'-triphosphate and can be blocked by selective desensitization of the P 2 -purinoceptor by a,/3-methylene adenosine 5'triphosphate. Vesicular storage of adenosine 5'-triphosphate and its release from sympathetic perivascular nerves has also been demonstrated. The functional significance of adenosine 5'triphosphate acting intraluminally as a vasodilator and extraluminally as a vasoconstrictor neuronal agent in the control of vascular tone is discussed. + = relaxation abolished or decreased by removal of endothelium; 0 = relaxation unaffected by removal of endothelium; NT = not tested.
THE potent and widespread vascular actions of purine nucleosides and nucleotides were first recognized in 1929 by Drury and Szent-Gyorgi, and it was subsequently shown that systemic administration of these compounds had profound effects on the blood pressure of a number of different species (Gillespie, 1934; Green and Stoner, 1950; Haddy and Scott, 1968 ). It has been proposed that adenosine mediates the vasodilation seen in various vascular beds under conditions in which oxygen delivery is decreased (Berne, 1963; Berne et al., 1974) .
In 1978, Burnstock suggested a subdivision of purinoceptors based on several criteria. At the Pjpurinoceptor, an agonist potency order of adenosine > adenosine 5'-monophosphate > adenosine 5'diphosphate > adenosine 5'-triphosphate (adenosine > AMP > ADP > ATP) was proposed; meth-ylxanthines such as theophylline were proposed to be selective antagonists, and occupation of the Pipurinoceptor was suggested to lead to changes in intracellular cyclic adenosine 5'-monophosphate (cAMP) levels. At the P 2 -purinoceptor, an agonist potency order of ATP > ADP > AMP > adenosine was proposed; it was further suggested that methylxanthines were not antagonists at the P 2 -purinoceptor; and, finally, that occupation of the P 2 -purinoceptor does not lead to changes in intracellular cAMP levels and, in some cases, evokes prostaglandin biosynthesis. Since its proposal, this classification has received much support and appears to have been widely accepted.
Pi-and P2-purinoceptor agonists affect the tone of a large number of isolated blood vessels from numerous vascular beds including the cerebral, cor-Circulation Research/VoZ. 58, No. 3, March 1986 onary, gastrointestinal, renal, hindlimb, and forelimb vascular beds (see Burnstock, 1980; Burnstock and Brown, 1981; Su, 1981 Su, , 1983 Su, , 1985 . Until recently, it was assumed that these effects were due to a direct action of purines on vascular smooth muscle. However, subsequent to the discovery by Furchgott and Zawadski (1980) that acetylcholineinduced vasodilation of isolated rabbit thoracic aorta was mediated by muscarinic receptors located on the vessel endothelium, it has been shown that adenosine 5 '-triphosphate (ATP) (and in some cases, adenosine) induces vasodilation via purinoceptors located on the endothelium of many blood vessels, both in vivo and in vitro (see Table 1 ). Removal of the endothelial cells abolishes these relaxations, and in many cases unmasks contractions to ATP (see below). In view of the findings described above, it has been suggested that these endothelial purinoceptors may play a role in local regulation of vascular tone by ATP (Pearson et al., 1983a; Kennedy et al., 1985) .
ATP has also been proposed to function as an excitatory cotransmitter from sympathetic nerves innervating both visceral organs (Fedan et al., 1981; Sneddon et al., 1982; Meldrum and Burnstock, 1983; Sneddon and Burnstock, 1984a; Burnstock and Sneddon, 1985) and blood vessels (Head et al., 1977; Muramatsu et al., 1981; Sneddon and Burnstock, 1984b; Kennedy et al., in press) . ATP released as a cotransmitter may also act as a prejunctional modulator of nerve activity following breakdown to adenosine (see Burnstock and Brown, 1981; Langer, 1981; Paton, 1981; Su, 1981 Su, , 1983 Su, , 1985 .
The aim of this paper is to consider the possibility of a dual function of ATP in the regulation of vascular tone: (1) as a vasodilator acting via inhibitory P 2 -purinoceptors located on endothelial cells following local release, and (2) as a vasoconstrictor acting via excitatory P 2 -purinoceptors located on vascular smooth muscle after release as a cotransmitter with noradrenaline from perivascular sympathetic nerves. The prejunctional inhibitory actions Gordon and Martin, 1983a Martin et al., 1985 Frank and Bevan, 1983 Kennedy and Bumstock, 1985a Cocks and Angus, 1983a De Mey and . Schematic representation of pathways by which purines may regulate vascular tone. + = excitatory response elicited, -= inhibitory response elicited, NA = noradrenaline, AD = adenosine, Pi = P,-purinoceptor, P 2 = Pi-purinoceptor, a = a-adrenoceptor, and EDRF = endothelium-derived relaxing factor. Broken lines between ATP and a and between NA and P 2 indicate the possibility of postjunctional synergistic interactions between noradrenaline and ATP. Broken lines between AD and P, and EDRF indicate that this pathway is less common.
of ATP and other purines have been reviewed elsewhere (see Burnstock and Brown, 1981; Langer, 1981; Paton, 1981; Su, 1981 Su, , 1983 . These proposed functions are illustrated in Figure 1 .
Endothelial Purinoceptors

Discovery and Distribution
It is now well established that ATP and its related purines, ADP, AMP, and adenosine, in common with several other vasoactive substances, including acetylcholine, substance P, bradykinin, histamine, and thrombin (see Furchgott, 1983) , can induce vasodilation via receptors located on the vessel endothelium. This followed the discovery by Furchgott and Zawadski (1980) that an intact endothelium was necessary in order for acetylcholine to relax the preconstricted isolated rabbit aorta. These studies indicated that acetylcholine stimulated the release of an endothelium-derived relaxing factor (EDRF), and it has been suggested that other substances, including ATP, that induce endothelium-dependent relaxations also stimulate the release of a factor (or factors) which diffuses to the adjacent smooth muscle cells and activates a mechanism for the relaxation of these cells (see Furchgott, 1983) . This suggestion is supported by recent results from studies with a cascade system based on the classical experiments of Loewi, which directly indicate release of EDRF from endothelial cells (Griffith et al., 1984; Angus and Cocks, 1984) .
ATP has been shown to induce vascular relaxation via inhibitory endothelial purinoceptors in a wide range of arteries and veins (see Table 1 ). Comparison of the relative activity of ATP and related purines gives a rank order of potency of ATP = ADP > AMP = adenosine (De Mey and Vanhoutte, 1981; Gordon and Martin, 1983a) indicating that ATP is acting via a P 2 -purinoceptor (Burnstock, 1978 ) (see Fig. 1 ). Furthermore, theophylline, an antagonist at Pi-purinoceptors, has been shown to have no effect on the endothelium-dependent actions of ATP (De Mey and Vanhoutte, 1981) , which is also consistent with ATP acting at a P 2 -purinoceptor (Burnstock, 1978) . However, in one case, namely the rabbit central ear artery, endothelium-dependent relaxations to ATP are antagonized by 8-phenyltheophylline, a potent antagonist at the Pi-purinoceptor (Smellie et al., 1979; Griffith et al., 1981) indicating that, in this tissue, ATP acts via a Pi-purinoceptor, possibly after breakdown to adenosine .
In contrast to ATP, in many arteries and in all veins studied to date, relaxation to adenosine has been shown to be unaffected by removal of the endothelium (Table 1) and adenosine has been shown to produce vascular relaxation via an inhibitory endothelial purinoceptor in only a few vessels (Table 1) . In many vessels, adenosine appears to induce vasodilation by direct action on the vascular smooth muscle (see Fig. 1 ). Adenosine-induced, endothelium-dependent relaxations of the rabbit central ear artery are antagonized by 8-phenyltheophylline , a potent antagonist at the Pi-purinoceptor, indicating that this action of adenosine is mediated via a Pi-purinoceptor (Burnstock, 1978) . Thus, endothelial P 2purinoceptors appear to have a wider distribution than endothelial Pi-purinoceptors. Differences also exist between vessel types, since larger endotheliumdependent inhibitory responses to ATP were seen in arteries than in veins .
Several compounds have been found to inhibit endothelium-dependent relaxations. Quinacrine (Furchgott, 1981 (Furchgott, , 1983 Cocks and Angus, 1983a) and 5,8,11,14-eicosatetraynoic acid (ETYA) (Furchgott, 1981 (Furchgott, , 1983 inhibit such responses to ATP (and other vasoactive substances) in rabbit aorta and dog circumflex coronary artery. However, they have no effect on endothelium-dependent relaxation to ATP in dog femoral artery . Anoxia also inhibits ATP-induced, endothelium-dependent relaxations (De Mey and Van-houtte, 1983) . Several other drugs have been shown to inhibit acetylcholine-induced, endothelium-dependent relaxations but have yet to be tested against those to ATP (see Furchgott, 1983) .
ATP has also been shown to have effects on endothelial cells, which appear to be unrelated to vasodilation. In endothelial cells isolated from pig aorta, ATP and related purines induce release of prostacyclin (PGI 2 ) (Gordon and Martin, 1983b) , with a rank order of potency of ATP = ADP > AMP = adenosine (Pearson et al., 1983b; Hellewell and Pearson, 1984) . However, PGI2 does not appear to be involved in ATP-induced, endothelium-dependent relaxation of this tissue since, at concentrations of up to 10~5 M, PGI 2 failed to relax histaminecontracted preparations, both with and without the endothelium being present (Gordon and Martin, 1983b) . A similar release of PGI 2 by ATP has also been shown from endothelial cells of rabbit and rat aorta and rabbit pulmonary artery (Boeynaems and Galand, 1983 ) and of bovine aorta by ADP (Van Coevarden and Boeynaems, 1984) . The possible relevance of this PGI 2 release is discussed below.
Cellular Sources of ATP
Regulation of vascular tone by ATP and related purines via inhibitory endothelial purinoceptors would have physiological relevance only if the extracellular concentration of these purines in the immediate vicinity of these receptors in vivo could become sufficiently high to lead to their activation. Under normal conditions, the level of purines in the blood is low, although it has been found to increase during exercise, or under conditions in which oxygen delivery to various vascular beds is decreased (Berne, 1963; Haddy and Scott, 1968; Forrester and Lind, 1969; Berne et ai., 1974; Sollevi and Fredholm, 1981) . Furthermore, many tissues, including the lungs (Pfleger and Schondorf, 1969 ; see also Pearson et al., 1983a , and references therein), have the capacity for uptake of circulating purines via a specific uptake system and/or for their degradation via ectoenzymes capable of rapidly metabolizing ATP, ADP, AMP, and adenosine (Pearson et al., 1978 (Pearson et al., , 1980 (Pearson et al., ,1983a Cusack et al., 1983) . Thus, these mechanisms are likely to limit the influence of circulating purines released from a tissue distant from their sites of action. Local release of purines close to their site of action may therefore be of greater importance. Intracellular stores of purines can be released from vascular cells in situ (Paddle and Burnstock, 1974; Pearson et al., 1983a; Born and Kratzer, 1984) , from endothelial and smooth muscle cells in culture (Pearson and Gordon, 1979; Nees and Gerlach, 1983) , and from blood cells during intravascular platelet aggregation (Mills et al., 1968; Born and Kratzer, 1984) .
By the highly sensitive firefly luciferin-luciferase assay method, the intraluminal ATP concentration has been measured during hypoxia and after damage to the vessel wall. Induction of hypoxia in the Circulation Research/Vol. 58, No. 3, March 1986 perfused guinea pig heart caused release of ATP to give levels of up to 0.64 pmol/ml in the venous effluent (Paddle and Burnstock, 1974) . However, metabolism and/or uptake of ATP by this tissue must be very efficient, since after ATP was added to the perfusate, only 1% could be detected in the venous effluent, indicating that the levels of ATP measured during hypoxia were underestimated by a factor of at least 100 (Paddle and Burnstock, 1974) . Puncture of rabbit, rat, and human vessels with a fine needle causes initial release of 2 X 10~7 M ATP, rising to about 2 X 10" 5 M within 5 minutes (Born and Kratzer, 1984) . These levels of ATP are not only suprathreshold for the endothelium-dependent vasodilation to ATP in most vessels tested, but in many vessels they are also in the range in which ATP causes 50% relaxation of induced tone (Furchgott, 1981; De Mey et al., 1981 Angus et al., 1983; Gordon and Martin, 1983a; Martin et al., 1985) . Thus, vascular cells can release purines in concentrations likely to be sufficient to activate local endothelial purinoceptors.
Possible Physiological Functions of Local Release of Purines
The local release of intracellular stores of ATP from endothelial cells may play an important role in the vasodilation initiated by hypoxia and ischemia. Berne (1963) proposed that adenosine was the most likely physiological mediator of the hyperemia associated with myocardial hypoxia, since adenosine and its degradative products were the compounds found in the greatest amounts in the effluent from isolated perfused cat hearts and in the coronary sinus blood of dog hearts after severe coronary hypoxia. However, it may be that ATP, released per se from cardiac endothelial cells, has a greater action initially than adenosine under these conditions, for the following reasons. (1) ATP is stored in high levels in cultured cardiac endothelial cells (see Nees and Gerlach, 1983) . The concentration of ATP in these cells is several times greater than the combined concentrations of ADP, AMP, and adenosine, and is also three times the concentration of ATP in cardiac myocytes (Nees and Gerlach, 1983) . (2) ATP release measured in isolated perfused guinea pig heart by the sensitive luciferin-luciferase assay shows a 2-to 7-fold increase in ATP in the coronary outflow after induction of hypoxia by gassing the perfusate with N 2 (Paddle and Burnstock, 1974) . However, when ATP was added to the perfusate, only 1% of it could be detected in the venous effluent, the major breakdown product being adenosine (Paddle and Burnstock, 1974) . ATP, therefore, appears to be very rapidly metabolized in the coronary vascular system, probably by ectoenzymes (as discussed above). Thus, the intracellular stores of ATP appear to be released from cardiac endothelial cells under ischemic and hypoxic conditions, probably either by passing across the cell membrane following changes in membrane permeability, or by diffusing out of the cell following cell damage. It appears that ATP can pass across cell membranes during hypoxia (Chaudry and Gould, 1970) . (3) ATP is more potent than adenosine in inducing coronary vasodilation (Winbury et al., 1953; Wolf and Berne, 1956; Walter and Bassenge, 1968; Moir and Downs, 1972; Toda et al., 1982) . (4) Methylxanthines block adenosine-induced coronary vasodilation but are usually reported to have little effect on that to ischemic hyperemia or ATP (Eikens and Wilcken, 1973; Giles and Wilcken, 1977; Olsson et al., 1978) .
Adenosine, however, is also likely to play an important longer-lasting role in hyperemia after ischemia or hypoxia, since it is also stored and released from cardiac endothelial cells (Nees and Gerlach, 1983) . The demonstration of ATP release from these cells, the greater cardiac vasodilatory potency of ATP, and the predominance of endothelial P 2 -purinoceptors, rather than Pi-purinoceptors, suggest that the rapid onset of vasodilation following hypoxia is in fact due to ATP, and that adenosine, either released from cardiac endothelial cells or produced after the metabolism of the ATP, plays a role in maintaining the vasodilation.
The local release of intracellular stores of ATP may also play an important role in the vasodilation seen in other vascular beds under conditions in which oxygen delivery to these beds is decreased. For instance, purine nucleosides have been collected in brain tissue and cerebrospinal fluid during ischemic hyperemia (Berne et al., 1974) and hypoxia . Furthermore, caffeine, an adenosine antagonist, reduces the intensity and duration of anoxia-induced hyperemia (Phillis et al., 1984) . These results suggest that adenosine may be the mediator of cerebrovascular blood flow under these conditions (Berne et al., 1983; Wahl, 1985) . However, cerebral arteries are more sensitive to ATP than to adenosine both in vitro (Hardebo and Edvinsson, 1979; Toda et al., 1982) and in situ (Forrester et al., 1979) . Thus, ATP may have a greater action initially than adenosine, which may then play a role in maintaining vasodilation. It has also been suggested that purines may play a role in the pathogenesis of the reactive hyperemia associated with the headache phase of migraine (Burnstock, 1981) .
Increased levels of ATP (Forrester and Lind, 1979 ) and adenosine (Berne et al., 1971) have been measured in the venous outflow from exercising muscle, and it has been proposed that these substances mediate exercise hyperemia (Burnstock, 1980; Forrester, 1981) . Similarly, ATP and adenosine may mediate the vascular response to ischemia in the kidney (Sakai et al., 1979; Osswald, 1983) , and to hypoxia in the lung (Mentzer et al., 1975; Burnstock, 1980) . Further experimentation is required to clarify the relative roles of ATP and adenosine in maintaining the blood flow under these conditions.
The local release of ATP may also be an important component in complex physiological mechanisms controlling local vascular tone and also platelet ag-gregation under normoxic conditions and after vascular injury. Besides vasodilation via endothelial cell purinoceptors, ATP can (1) induce release of PGI 2 from endothelial cells (see above), which has variable effects on vascular tone depending on the vessel being studied, and which also inhibits platelet aggregation (Bunting et al., 1976; Gordon and Martin, 1983b) ; (2) directly inhibit aggregation (see Haslam and Cusack, 1981) ; and (3) induce both endothelium-dependent vasodilation (see Table 1 ) and platelet aggregation (see Haslam and Cusack, 1981; Born and Kratzer, 1984) after breakdown by ecto ATPase to ADP (Pearson et al., 1980) . Platelet aggregation introduces further influences on vascular tone. In isolated vessels with an intact endothelial layer, aggregating platelets cause both vasoconstriction and vasodilation (Cohen et al., 1983) . Removal of the endothelial layer potentiates the vasoconstriction and abolishes the vasodilation (Cohen et al., 1983) . These effects probably are due to release from platelets of intracellular stores of vasoactive substances such as 5-hydroxytryptamine (Mills et al., 1968) , which causes both endothelium-dependent vasodilation and direct vasoconstriction (Cocks and Angus, 1983b; Cohen et al., 1984) and of ADP (Houston et al., 1985) . Thrombin, which is also involved in clot formation, also induces release of ATP from endothelial cells in culture (Pearson and Gordon, 1979) and endothelium-dependent vasodilation . Thus, ATP (and ADP) may be involved in the action of these and other substances.
The net effect of the actions and interactions described above may depend on the structural integrity of the vascular wall. If the endothelial cell layer is intact, platelet aggregation may lead to the release of sufficient levels of purines and other substances to ensure endothelium-dependent vasodilation and dispersion of the forming clot. If, however, the endothelial cell layer is damaged and vascular smooth muscle is exposed, the direct contractile effects of ATP and other substances may be great enough to overcome the vasodilation and so induce vasospasm, further clot formation, and perhaps, ultimately, cessation of blood flow through the vessel. Such a mechanism may be involved in common vascular disorders. Further experimentation is required to determine the physiological relevance of the mechanism described above.
ATP as a Cotransmitter with Noradrenaline from Perivascular Sympathetic Nerves on the Adventitial-Medial Border
Pharmacological Studies
The concept that each nerve cell can synthesize, store, and release only one neurotransmitter (Dale's' principle) has been challenged in recent years (Burnstock, 1976) . The existence of nerves that can synthesize, store, and release more than one pharmacologically active substance is now widely accepted (see Cuello, 1982; Osborne, 1983; Burnstock, 1983) , and ATP and noradrenaline have been shown to act as cotransmitters from sympathetic nerves innervating the guinea pig vas deferens (Fedan et al., 1981; Sneddon et al., 1982; Meldrum and Burnstock, 1983; Sneddon and Burnstock, 1984a) .
In many isolated blood vessels, ATP has been shown to cause vasodilation or, at higher concentrations, vasoconstriction followed by vasodilation (Burnstock and Brown, 1981) . Thus, it would appear that ATP is unlikely to be an excitatory cotransmitter with noradrenaline from the perivascular sympathetic nerves innervating such vessels. However, the recent discovery of inhibitory P2-purinoceptors on the endothelium of many blood vessels (see above) suggests that ATP-induced vasoconstriction may be masked by its potent inhibitory effects mediated via the endothelium. This was found to be so in a recent study by Kennedy et al. (1985) on the isolated rat femoral artery. In preparations with tone raised by 10~6 M noradrenaline and with the vessel endothelial cell layer intact, ATP produced relaxations at low concentrations and transient contractions followed by relaxation at higher concentrations. Removal of the endothelium abolished relaxations, and contractions were seen instead, often at concentrations that produced no change in vessel tone in the presence of endothelium. Clearly, the responses produced by ATP here are the sum of its inhibitory action at P 2purinoceptors located on the endothelium and its excitatory action at P 2 -purinoceptors located on the smooth muscle, and this is very likely to be the case in many other vessels (see Fig. 1 ). «,/3-Methylene ATP, a structural analogue of ATP, has been shown to be significantly more potent than ATP as a contractile agent in several visceral tissues Kasakov and Burnstock, 1983) and blood vessels (Chapal and Loubatieres-Mariani, 1983; Kennedy et al., 1985; Burnstock, 1985a, 1985b) . However, it appears to be much less potent than ATP at the inhibitory P 2purinoceptor located on vascular endothelial cells (Kennedy et al., 1985) . This compound may, therefore, be of great use in the study of vascular contractions mediated by P 2 -purinoceptors, having little or no complicating action at inhibitory purinoceptors.
Biochemical studies indicate that noradrenaline and ATP may be stored together in sympathetic neurones in various ratios (Stjarne and Lishajko, 1966; Geffen and Livett, 1971; Smith, 1972; Lagercrantz and Stjarne, 1974) , and coexistence of NA and ATP has been suggested to occur in sympathetic perivascular nerves of the rabbit central ear artery (Head et al., 1977) , dog basilar artery (Muramatsu et al., 1981) , rat tail artery (Sneddon and Burnstock, 1984b) , and rat portal vein (Burnstock et al., 1984) . An essential condition required to support the cotransmission hypothesis is the demonstration of neuronal release of ATP with noradrenaline following the stimulation of noradrenergic nerves. By
measuring [ 3 H]purine release (after [ 3 H]adenosine
Circulation Research/Vo/. 58, No. 3, March 1986 preloading) as an indication of ATP release (since ATP appears to be broken down rapidly following release into the extracellular fluid), noradrenergic nerve stimulation induces purine release which is tetrodotoxin-and guanethidine-sensitive, in several blood vessels (Su, 1975; Levitt and Westfall, 1982; Katsuragi and Su, 1980 ,1982a , 1982b , 1982c . In these experiments, the purines appear to be released from a neuronal source, rather than from a postjunctional source. For example, in the rabbit pulmonary artery, KCl-induced [ 3 H]purine efflux was unaffected by reserpine or phentolamine, but was greatly decreased by removal of Ca ++ , by 6hydroxydopamine pretreatment, or by cold storage, whereas [ 3 H]purine efflux induced by exogenous adrenaline was inhibited by phentolamine but unaffected by 6-hydroxydopamine or cold storage (Katsuragi and Su, 1980) . Part of the neurogenic purine release in rabbit portal vein shows a similar sensitivity to 6-hydroxydopamine pretreatment (Levitt and Westfall, 1982) .
Electrophysiological Studies
Increasingly, electrophysiological experiments involving intracellular penetration of vascular smooth muscle with microelectrodes are producing results that are also consistent with ATP and noradrenaline being cotransmitters from perivascular sympathetic nerves. These experiments have shown that, in a variety of blood vessels, electrical stimulation of perivascular nerves induces excitatory junction potentials (EJP) in the vascular smooth muscle, which are not inhibited by a-adrenoceptor blockade with prazosin or phentolamine but which are abolished by guanethidine or tetrodotoxin, indicating that they are a consequence of neuronal excitation. Such responses are seen in a number of vessels (see Table  2 ). Pharmacological studies have shown that contractions to perivascular nerve stimulation are, in some of these vessels, also resistant to a-adrenoceptor blockade (see Table 3 ). However, there are two types of inconsistency in the literature. First, in some vessels, e.g., rat tail artery, EJP, but not neurogenic contractions, are resistant to a-adrenoceptor blockade. Second, for example, in the rabbit central ear artery, some authors have reported that neurogenic contractions are virtually abolished by a-adrenoceptor antagonists (Owen et al., 1983; see Bevan et al., 1980) , whereas others have found a component which is resistant to a-adrenoceptor blockade (Holman and Surprenant, 1980; Suzuki and Kou, 1983; Kennedy et al., 1985b) . Both of these inconsistencies appear to be due to differences in the parameters of stimulation used. Kennedy et al. (in press) have shown in the rabbit central ear artery that long trains of stimulation applied until a maximum response was reached produced contractions which were largely, although not totally, inhibited by a-antagonists. However, contractions to a short, i.e., 1-second, train of stimulation had a much larger component which was resistant to a-adrenoceptor Hirst et al., 1982 Fujiwara et al., 1982 Kajiwara et al., 1981 Holman and Surprenant, 1980 Suzuki and Kou, 1983 Suzuki et al., 1984 Kou et al., 1982 Kuriyama and Makita, 1983 Kuriyama and Suyama, 1983 Itoh et al., 1983 Asada et al., 1983 Kuriyama and Makita, 1984 Kou et al., 1984 Suzuki, 1984 Fujiwara et al., 1982 Makita, 1983 Holman and Surprenant, 1980 Cheung, 1985 Hirst and Neild, 1980 Holman and Surprenant, 1980 Cheung, 1982 Itoh et al., 1983 Sneddon and Burnstock, 1984b Lee et al., 1976 Lee et al., 1980 Holman and Surprenant, 1980 Suzuki and Kou, 1983 Kennedy et al., in press Kou et al., 1982 Muramatsu et al., 1984 Kuriyama and Makita, 1983 Holman and Surprenant, 1980 Holman and Surprenant, 1980 Cheung, 1984 blockade. Thus, the relative contribution of noradrenaline to neurogenic contractions is highly dependent upon the parameters of stimulation used. Even with ideal stimulation parameters for producing the maximum nonadrenergic component of the neurogenic contraction, it seems likely that the relative contribution of this component to the total neurogenic contraction will vary between vessels. For example, with short trains of stimulation the nonadrenergic component of contraction can be 60% of the total contraction in the rabbit central ear artery (Kennedy et al., in press) , whereas, in the rat tail artery, the maximum contribution of the non-adrenergic component to the overall contraction is only 30% (Kennedy and Mathieson, unpublished observations) . Great differences can thus be seen between different vessels.
The differences between the responses to a 1second train of stimulation and continuous stimulation until a maximum is reached must be considered in relation to physiological patterns of autonomic nerve activity. Folkow (1952) proposed that the maximum firing rate in sympathetic neurones was rarely greater than 10 Hz. However, this represents an average of maximum firing rate. Furthermore, firing is highly irregular (see Nilsson et al., 1985) . Therefore, sympathetic fibers may fire at frequencies far greater than 10 Hz. Sympathetic vasoconstriction has recently been shown to be greater when a constant number of pulses are delivered in bursts rather than continuously (Andersson, 1983; Nilsson et al., 1985) . Similar results have been found when a variety of nonvascular responses have been measured (Edwards and Bloom, 1982) . Thus, 1-second bursts of stimulation may have a greater physiological relevance than continuous stimulation until a maximum is reached.
It has been suggested that these a-adrenoceptor antagonist-resistant responses are due to the presence in the neuromuscular junction of a class of adrenoceptors activated by high concentrations of noradrenaline, and named 7-adrenoceptors. The possible existence of these receptors has been debated and reviewed (Neild and Zelcer, 1982; Angus, 1982; Bevan, 1984; Neild and Hirst, 1984) . Alternatively, these responses may be mediated by ATP. Burnstock (1984b, 1984c) have sug-gested that, in the rat tail artery at least, ATP mediates the a-antagonist-resistant EJP (see Fig. 1 ) since, in this tissue, desensitization of the P2-purinoceptor by a,/3-methylene ATP, a structural analogue of ATP, inhibits EJP produced by perivascular nerve stimulation. However, a slowly developing depolarization was unaffected by this treatment, but was inhibited by phentolamine, indicating that a,fimethylene ATP was not acting via a prejunctional inhibitory mechanism. It may be that ATP has a similar function in the other vessels listed in Tables 2 and 3, but this hypothesis awaits experimental confirmation. Indeed, in the rabbit ear artery, iontophoretic application of ATP induces a depolarization with a rapid decay, which mimicks nerveinduced EJP Suzuki, 1985) , whereas noradrenaline evokes a depolarization which decays with a slow time course, unlike nerveinduced EJP . Furthermore, in several vessels, superfusion with ATP evokes a depolarization, but noradrenaline has no effect on membrane potential (Karashima and Kuriyama, 1981; Fujiwara et al., 1982) .
Similarly, Kennedy et al. (in press ) have suggested that ATP mediates a-adrenoceptor antagonist-resistant neurogenic contractions of the isolated rabbit central ear artery. In this study, electrical stimulation of the perivascular nerves for either 1 second, or continuously until a maximum response was reached, produced frequency-dependent contractions that were sensitive to tetrodotoxin and guanethidine. Contractions to continuous stimulation were significantly greater than those to a 1-second train of stimulation. Prazosin (10~6 M) significantly reduced, but did not abolish, all neurogenic contractions, such that contractions to both a 1-second train and to continuous stimulation were of a similar magnitude. A higher concentration'of prazosin (10~5 M) had no additional inhibitory effect on neurogenic contractions even though it further significantly inhibited contractions to exogenous noradrenaline. The greatest resistance to a-adrenoceptor blockade was seen at low frequencies. Desensitization of the postjunctional P2-purinoceptor by repeated administration of a,|8-methylene ATP inhibited the nonadrenergic neurogenic contractions and contractions to exogenous ATP, but had no effect on contractions to exogenous noradrenaline. Thus, ATP and noradrenaline appear to be excitatory cotransmitters from sympathetic perivascular nerves innervating the rabbit central ear artery. The relative contribution of each compound to neurogenic contractions is highly dependent on the parameters of stimulation used.
Functional Significance of Cotransmission
The functional significance of cotransmission is, as yet, unclear but several possible reasons for this arrangement can be considered. (1) There may be differences in the time course of release, diffusion, postjunctional action, or inactivation of cotransmit-Circulation Research/Vol. 58, No. 3, March 1986 ters. The results of some of the electrophysiological experiments discussed above are consistent with this idea (see references in Table 2 ). The nonadrenergic component of the electrical response following perivascular nerve stimulation of many of these blood vessels has a rapid onset and short duration, whereas the adrenergic component develops more slowly and is longer lasting. For example, the electrical response of the isolated rat tail artery following perivascular nerve stimulation consists of (a) rapid EJP which are insensitive to phentolamine but are blocked by desensitization of the P 2 -purinoceptor by a,/3-methylene ATP, and (b) a slow depolarization which is blocked by phentolamine but is unaffected by desensitization of the P2-purinoceptor by a,|8-methylene ATP (Sneddon and Burnstock, 1984b) . (2) Co-release of two transmitters may be linked to a postjunctional synergistic interaction between these two substances (see Fig. 1 ). ATP and noradrenaline show synergistic potentiation in several visceral organs (see Stone, 1983 ) and blood vessels (Krishnamurty and Kadowitz, 1983; Burnstock et al., 1984; Kennedy et al., 1985) . These results may reflect an intimate association between a-adrenoceptors and P 2 -purinoceptors, perhaps similar to the general models for interaction between two receptors as discussed by Costa (1982) . Alternatively, these synergistic interactions may simply reflect a general sensitization of the vascular smooth muscle cell membrane by these compounds. Postjunctional interactions between purines and other substances have been reviewed recently (Stone, 1983) . (3) Finally, the functional significance of co-storage of transmitters may depend on the functional activity of the nerve terminal, i.e., the relative rates of release of cotransmitters may change according to the number, frequency, and pattern of impulses reaching the nerve terminal. Parasympathetic nerves innervating blood vessels associated with cat submaxillary gland appear to release both acetylcholine and vasoactive intestinal polypeptide (VIP) as inhibitory transmitters. However, acetylcholine is optimally released at frequencies well below those required to give effective release of VIP. Optimal release and response to endogenous VIP is seen when short bursts of high frequency of stimulation are applied (Edwards and Bloom, 1982) .
The general occurrence and relative importance of these three mechanisms is at present the subject of a great deal of research. It is likely that in the future many more neuronal systems will be shown to contain and release cotransmitters.
Concluding Comments and Summary
This paper has considered the evidence for a dual function of ATP in regulation of vascular tone. ATP can act via P 2 -purinoceptors located on vascular endothelial cells to cause release of an endotheliumderived relaxing factor which diffuses to the vascular smooth muscle and induces vasodilation. The studies discussed indicate that the main source of intra-luminal ATP is likely to be endothelial cells, and its release can be measured during pathophysiological conditions such as ischemia and hypoxia in amounts sufficient to activate these endothelial P 2 -purinoceptors. Studies also indicate release of ATP during intravascular platelet aggregation and from intact and damaged vascular smooth muscle cells. This local release of ATP is therefore likely to be an important component in the complex physiological mechanisms controlling local vascular tone under normoxic conditions during vessel injury.
Evidence is also presented for ATP acting as an excitatory cotransmitter with noradrenaline from sympathetic perivascular nerves and causing vasoconstriction via excitatory P 2 -purinoceptors located on vascular smooth muscle. Vesicular storage of ATP and its release from perivascular nerves has been demonstrated. In many blood vessels, the postjunctional mechanical and electrical responses to sympathetic perivascular nerve stimulation contain a component that is resistant to blockade of the aadrenoceptor. This nonadrenergic response can be mimicked by ATP and can be blocked by selective desensitization of the P 2 -purinoceptor by a,/3-methylene ATP. For example, nonadrenergic EJP in the isolated rat tail artery and nonadrenergic contractions of the isolated rabbit central ear artery can be blocked by desensitization of the P 2 -purinoceptor by a,/?-methylene ATP, a structural analogue of ATP. It is suggested that in this vessel, and in others, ATP and noradrenaline act as cotransmitters from sympathetic nerves in a manner analogous to those innervating the guinea pig vas deferens. The functional significance of cotransmission remains unclear at present, but several possible mechanisms have been discussed.
ATP can thus act as both an intravascular and as a neuronal mediator of vascular tone. The net effect of these actions is likely to depend on the site of release of ATP and the structural and functional integrity of the vessel.
